The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
The aldo-keto reductases (AKRs): Overview
Open accessAbstract
The aldo-keto reductase (AKR) protein superfamily contains > 190 members that fall into 16 families and are found in all phyla. These enzymes reduce carbonyl substrates such as: sugar aldehydes; keto-steroids, keto-prostaglandins, retinals, quinones, and lipid peroxidation byproducts. Exceptions include the reduction of steroid double bonds catalyzed by AKR1D enzymes (5β-reductases); and the oxidation of proximate carcinogen trans-dihydrodiol polycyclic aromatic hydrocarbons; while the (β-subunits of potassium gated ion channels (AKR6 family) control Kv channel opening. AKRs are usually 37 kDa monomers, have an (α/β)8-barrel motif, display large loops at the back of the barrel which govern substrate specificity, and have a conserved cofactor binding domain. AKRs catalyze an ordered bi bi kinetic mechanism in which NAD(P)H cofactor binds first and leaves last. In enzymes that favor NADPH, the rate of release of NADP+ is governed by a slow isomerization step which places an upper limit on kcat. AKRs retain a conserved catalytic tetrad consisting of Tyr55, Asp50, Lys84, and His117 (AKR1C9 numbering). There is conservation of the catalytic mechanism with short-chain dehydrogenases/reductases (SDRs) even though they show different protein folds. There are 15 human AKRs of these AKR1B1, AKR1C1-1C3, AKR1D1, and AKR1B10 have been implicated in diabetic complications, steroid hormone dependent malignancies, bile acid deficiency and defects in retinoic acid signaling, respectively. Inhibitor programs exist worldwide to target each of these enzymes to treat the aforementioned disorders. Inherited mutations in AKR1C and AKR1D1 enzymes are implicated in defects in the development of male genitalia and bile acid deficiency, respectively, and occur in evolutionary conserved amino acids. The human AKRs have a large number of nsSNPs and splice variants, but in many instances functional genomics is lacking. AKRs and their variants are now poised to be interrogated using modern genomic and informatics approaches to determine their association with human health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521
PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/bj3510067 · Cited by 649
Self-citationComparative anatomy of the aldo–keto reductase superfamily
JEZ, J. M., BENNETT, M. J., SCHLEGEL, B. P., LEWIS, M., & PENNING, T. M. (1997) · Biochemical Journal · doi:10.1042/bj3260625 · Cited by 604
Self-citationThe Aldo-Keto Reductase Superfamily
Bohren, K. M., Bullock, B., Wermuth, B., & Gabbay, K. H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60566-6 · Cited by 453
Wilson, D. K., Bohren, K. M., Gabbay, K. H., & Quiocho, F. A. (1992) · Science · doi:10.1126/science.1621098 · Cited by 432
Aldo-Keto Reductases and Bioactivation/Detoxication
Jin, Y., & Penning, T. M. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105337 · Cited by 383
Self-citationA new nomenclature for the aldo-keto reductase superfamily
Jez, J. M., Flynn, T. G., & Penning, T. M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)84253-0 · Cited by 354
Self-citationThe backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347
Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus
Gabbay, K. H. (1975) · Annual Review of Medicine · doi:10.1146/annurev.me.26.020175.002513 · Cited by 329
The aldo-keto reductase superfamily homepage
Hyndman, D., Bauman, D. R., Heredia, V. V., & Penning, T. M. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00193-x · Cited by 314
Self-citationAldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic Patients
Judzewitsch, R. G., Jaspan, J. B., Polonsky, K. S., Weinberg, C. R., Halter, J. B., Halar, E., Pfeifer, M. A., Vukadinovic, C., Bernstein, L., Schneider, M., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301203080302 · Cited by 313
Fukumoto, S.-I., Yamauchi, N., Moriguchi, H., Hippo, Y., Watanabe, A., Shibahara, J., Taniguchi, H., Ishikawa, S., Ito, H., Yamamoto, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1238 · Cited by 289
Flück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248
Palackal, N. T., Lee, S. H., Harvey, R. G., Blair, I. A., & Penning, T. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112424200 · Cited by 222
Self-citationOppermann, U. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105316 · Cited by 220
Hotta, N., Toyota, T., Matsuoka, K., Shigeta, Y., Kikkawa, R., Kaneko, T., Takahashi, A., Sugimura, K., Koike, Y., Ishii, J., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1776 · Cited by 217
Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review
Schemmel, K. E., Padiyara, R. S., & D'Souza, J. J. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2009.07.005 · Cited by 203
Burczynski, M. E., Sridhar, G. R., Palackal, N. T., & Penning, T. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006655200 · Cited by 190
Self-citationGallego, O., Ruiz, F. X., Ardèvol, A., Domínguez, M., Alvarez, R., de Lera, A. R., Rovira, C., Farrés, J., Fita, I., & Parés, X. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705659105 · Cited by 182
Bohren, K. M., Grimshaw, C. E., Lai, C. J., Harrison, D. H., Ringe, D., Petsko, G. A., & Gabbay, K. H. (1994) · Biochemistry · doi:10.1021/bi00174a007 · Cited by 171
Srivastava, S., Chandra, A., Bhatnagar, A., Srivastava, S. K., & Ansari, N. H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2835 · Cited by 161
AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer
Rižner, T. L., Šmuc, T., Rupreht, R., Šinkovec, J., & Penning, T. M. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.009 · Cited by 159
Self-citationDesmond, J. C., Mountford, J. C., Drayson, M. T., Walker, E. A., Hewison, M., Ride, J. P., Luong, Q. T., Hayden, R. E., Vanin, E. F., & Bunce, C. M. (2003) · PubMed · Cited by 150
Schlegel, B. P., Jez, J. M., & Penning, T. M. (1998) · Biochemistry · doi:10.1021/bi9723055 · Cited by 145
Self-citationByrns, M. C., Steckelbroeck, S., & Penning, T. M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.008 · Cited by 145
Self-citationKONDO, K., KAI, M., SETOGUCHI, Y., EGGERTSEN, G., SJÖBLOM, P., SETOGUCHI, T., OKUDA, K., & BJÖRKHEM, I. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19947.x · Cited by 139
Hotta, N., Kawamori, R., Fukuda, M., Shigeta, Y., & The Aldose Reductase Inhibitor–Diabetes Complications Trial Study Group (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03684.x · Cited by 139
Hoog, S. S., Pawlowski, J. E., Alzari, P. M., Penning, T. M., & Lewis, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2517 · Cited by 137
Self-citationBurczynski, M. E., Harvey, R. G., & Penning, T. M. (1998) · Biochemistry · doi:10.1021/bi972725u · Cited by 134
Self-citationRižner, T. L., Lin, H. K., Peehl, D. M., Steckelbroeck, S., Bauman, D. R., & Penning, T. M. (2003) · Endocrinology · doi:10.1210/en.2002-0032 · Cited by 132
Self-citationcDNA cloning, expression and characterization of human prostaglandin F synthase1
Suzuki-Yamamoto, T., Nishizawa, M., Fukui, M., Okuda‐Ashitaka, E., Nakajima, T., Ito, S., & Watanabe, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01551-3 · Cited by 131
Gallego, O., Belyaeva, O. V., Porté, S., Ruiz, F. X., Stetsenko, A. V., Shabrova, E. V., Kostereva, N. V., Farrés, J., Parés, X., & Kedishvili, N. Y. (2006) · Biochemical Journal · doi:10.1042/bj20051988 · Cited by 131
Yepuru, M., Wu, Z., Kulkarni, A. L., Yin, F., Barrett, C. M., Kim, J.-H., Steiner, M. S., Miller, D. D., Dalton, J. T., & Narayanan, R. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1151 · Cited by 126
Lemonde, H. A., Custard, E. J., Bouquet, J., Duran, M., Overmars, H., Scambler, P. J., & Clayton, P. T. (2003) · Gut · doi:10.1136/gut.52.10.1494 · Cited by 125
Evidence for a G Protein‐Coupled γ‐Hydroxybutyric Acid Receptor
Snead, O. C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751986.x · Cited by 124
Bauman, D. R., Steckelbroeck, S., Williams, M. V., Peehl, D. M., & Penning, T. M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0287 · Cited by 120
Self-citationByrns, M. C., Duan, L., Lee, S. H., Blair, I. A., & Penning, T. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.009 · Cited by 116
Self-citationΔ4-3-Oxosteroid 5β-reductase deficiency causing neonatal liver failure and hemochromatosis
Shneider, B. L., Setchell, K. D. R., Whitington, P. F., Neilson, K. A., & Suchy, F. J. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70310-8 · Cited by 116
Crystal Structure of Human Prostaglandin F Synthase (AKR1C3),
Komoto, J., Yamada, T., Watanabe, K., & Takusagawa, F. (2004) · Biochemistry · doi:10.1021/bi036046x · Cited by 109
THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEX
Borhani, D. W., Harter, T. M., & Petrash, J. M. (1992) · Worldwide Protein Data Bank · doi:10.2210/pdb1abn/pdb · Cited by 99
Allopregnanolone in Women with Premenstrual Syndrome
Bičı́ková, M., DIBBELT, L., Hiill, M., Hampl, R., & Stárka, L. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978871 · Cited by 96
Grimshaw, C. E., Bohren, K. M., Lai, C.-J., & Gabbay, K. H. (1995) · Biochemistry · doi:10.1021/bi00044a012 · Cited by 95
Structure of 3α-Hydroxysteroid/Dihydrodiol Dehydrogenase Complexed with NADP+
Bennett, M. J., Schlegel, B. P., Jez, J. M., Penning, T. M., & Lewis, M. (1996) · Biochemistry · doi:10.1021/bi9604688 · Cited by 92
Self-citationThe crystal structure of the aldose reductase.NADPH binary complex.
Borhani, D. W., Harter, T. M., & Petrash, J. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35840-x · Cited by 92
Kim, K., Pearl, P. L., Jensen, K., Snead, O. C., Malaspina, P., Jakobs, C., & Gibson, K. M. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3470 · Cited by 84
Di Costanzo, L., Drury, J. E., Penning, T. M., & Christianson, D. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801778200 · Cited by 79
Khanim, F. L., Hayden, R. E., Birtwistle, J., Lodi, A., Tiziani, S., Davies, N., Ride, J. P., Viant, M. R., Günther, U. L., Mountford, J. C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008147 · Cited by 76
Atalla, A., Breyer-Pfaff, U., & Maser, E. (2000) · Xenobiotica · doi:10.1080/00498250050119826 · Cited by 75
Ratnam, K., Ma, H., & Penning, T. M. (1999) · Biochemistry · doi:10.1021/bi982838t · Cited by 68
Self-citationGonzales, E., Cresteil, D., Baussan, C., Dabadie, A., Gerhardt, M.-F., & Jacquemin, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.024 · Cited by 68
Purification and characterization of delta 4-3-ketosteroid 5 beta-reductase.
Okuda, A., & Okuda, K. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42821-3 · Cited by 67
Selective Inhibition of the Tumor Marker Aldo-keto Reductase Family Member 1B10 by Oleanolic Acid
Takemura, M., Endo, S., Matsunaga, T., Soda, M., Zhao, H.-T., El-Kabbani, O. A. L., Tajima, K., Iinuma, M., & Hara, A. (2011) · Journal of Natural Products · doi:10.1021/np200118q · Cited by 67
Kikuchi, A., Furutani, T., Azami, H., Watanabe, K., Niimi, T., Kamiyama, Y., Kuromitsu, S., Baskin-Bey, E. S., Heeringa, M. J., Ouatas, T., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0130-5 · Cited by 65
Liu, Z., Yan, R., Al-Salman, A., et al. (2011) · Biochemical Journal · doi:10.1042/bj20111322 · Cited by 64
Engineering Steroid 5β-Reductase Activity into Rat Liver 3α-Hydroxysteroid Dehydrogenase
Jez, J. M., & Penning, T. M. (1998) · Biochemistry · doi:10.1021/bi980294p · Cited by 63
Self-citationByrns, M. C., Mindnich, R., Duan, L., & Penning, T. M. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.012 · Cited by 60
Self-citationCooper, W. C., Jin, Y., & Penning, T. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703414200 · Cited by 58
Self-citationStructure of porcine aldehyde reductase holoenzyme
El-Kabbani, O. A. L., Judge, K. W., Ginell, S. L., Myles, D. A. A., DeLucas, L. J., & Flynn, T. G. (1995) · Nature Structural Biology · doi:10.1038/nsb0895-687 · Cited by 58
The Crystal Structure of Rat Liver AKR7A1
Kozma, E., Brown, E. H., Ellis, E. M., & Lapthorn, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110808200 · Cited by 56
Grimshaw, C. E., Bohren, K. M., Lai, C.-J., & Gabbay, K. H. (1995) · Biochemistry · doi:10.1021/bi00044a014 · Cited by 52
Drury, J. E., Mindnich, R., & Penning, T. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127779 · Cited by 51
Self-citationSynthesis and Catabolism of γ-Hydroxybutyrate in SH-SY5Y Human Neuroblastoma Cells
Lyon, R. C., Johnston, S. M., Watson, D. G., McGarvie, G. M., & Ellis, E. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702465200 · Cited by 48
Schlegel, B. P., Ratnam, K., & Penning, T. M. (1998) · Biochemistry · doi:10.1021/bi980475r · Cited by 45
Self-citationNADPH binding to β-subunit regulates inactivation of voltage-gated K+ channels
Tipparaju, S. M., Liu, S., Barski, O. A., & Bhatnagar, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.102 · Cited by 44
Hu, X., Li, S., Yang, G., Liu, H., Boden, G. H., & Li, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087096 · Cited by 43
Matsumoto, T., Ono, Y., Kuromiya, A., Toyosawa, K., Ueda, Y., & Bril, V. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08071fp · Cited by 42
Tipparaju, S. M., Li, X., Kilfoil, P. J., Xue, B., Uversky, V. N., Bhatnagar, A., & Barski, O. A. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1093-z · Cited by 40
Aldose Reductase Inhibition Prevents Endotoxin-Induced Inflammatory Responses in Retinal Microglia
Chang, K., Ponder, J., LaBarbera, D. V., & Petrash, J. M. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13487 · Cited by 39
Structure and catalytic mechanism of human steroid 5β-reductase (AKR1D1)
Costanzo, L. D., Drury, J. E., Christianson, D. W., & Penning, T. M. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.013 · Cited by 39
Self-citationGene analysis in δ-3-oxosteroid 5β–reductase deficiency
Sumazaki, R., Nakamura, N., Shoda, J., Kurosawa, T., & Tohma, M. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62828-0 · Cited by 37
Khanim, F. L., Davies, N., Veliça, P., Hayden, R., Ride, J. P., Pararasa, C., Chong, M., Günther, U. L., Veerapen, N., Winn, P. J., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.83 · Cited by 36
Liu, H., Luo, Y., Zhang, T., Zhang, Y., Qu, W., Li, Y., Chung, S. S. M., Oates, P. J., & Yang, J. (2011) · Diabetologia · doi:10.1007/s00125-011-2045-4 · Cited by 33
Ma, H., Ratnam, K., & Penning, T. M. (1999) · Biochemistry · doi:10.1021/bi991659o · Cited by 25
Self-citationEl-Kabbani, O. A. L., Scammells, P. J., Day, T., Dhagat, U., Endo, S., Matsunaga, T., Soda, M., & Hara, A. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.052 · Cited by 21
Gonzales, E. M., Cresteil, D., Baussan, C., Dabadie, A., Gerhardt, M., & Jacquemin, E. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200406001-00312 · Cited by 20
The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function
Mindnich, R., Drury, J. E., & Penning, T. M. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.12.020 · Cited by 16
Alternative splicing in the aldo–keto reductase superfamily: Implications for protein nomenclature
Barski, O. A., Mindnich, R., & Penning, T. M. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.12.012 · Cited by 11
Self-citationKozma, E., Brown, E. H., Ellis, E. M., & Lapthorn, A. J. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00186-2 · Cited by 10
Kimura, A., Nittono, H., Takei, H., & Kurosawa, T. (2000) · Pediatrics International · doi:10.1046/j.1442-200x.2000.01284.x · Cited by 6
Gene analysis in Δ^4-3-oxosteroid 5β-reductase deficiency
Sumazaki, R. (1997) · The Lancet · Cited by 4
Cited by
Nrf2–ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms
Shaw, P., & Chattopadhyay, A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29219 · Cited by 431
Cajigas, I., Chakraborty, A., Swyter, K. R., Luo, H., Bastidas, M., Nigro, M., Morris, E. R., Chen, S., VanGompel, M. J. W., Leib, D., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.024 · Cited by 82
Regulation of antioxidant defense and glyoxalase systems in cyanobacteria
Rai, R., Singh, S., Rai, K. K., Raj, A., Sriwastaw, S., & Rai, L. C. (2021) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2021.09.037 · Cited by 51
Han, X., Wu, X., Liu, F., Chen, H., & Hou, H. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117942 · Cited by 21
Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition
Liu, M., Qin, X., Li, J., Jiang, Y., Jiang, J., Guo, J., Xu, H., Wang, Y., Bi, H., & Wang, Z. (2024) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp05985e · Cited by 7
Metadata
- Authors
- Penning, T. M.
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 234
- Pages
- 236-246
- ISSN
- 0009-2797 (ISSN-L)
- OpenAlex
- W2078086567
- Cited by
- 543
- References
- 80
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.